Shilpa Medicare Stock Screener | Share Price & Fundamental Analysis
SHILPAMED
Pharmaceuticals
Screen Shilpa Medicare share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹318.15
▼
-0.15 (-0.05%)
Share Price BSE
₹318.20
▲
0.10 (0.03%)
Market Cap
₹6,172.56 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.57
EPS (TTM)
₹8.04
Dividend Yield
0.16%
Debt to Equity
0.36
52W High
₹847.75
52W Low
₹315.85
Operating Margin
29.00%
Profit Margin
11.83%
Revenue (TTM)
₹372.00
EBITDA
₹110.00
Net Income
₹44.00
Total Assets
₹3,311.00
Total Equity
₹2,364.00
Shilpa Medicare Share Price History - Stock Screener Chart
Screen SHILPAMED historical share price movements with interactive charts. Analyze price trends and patterns.
Shilpa Medicare Company Profile - Fundamental Screener
Screen Shilpa Medicare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHILPAMED shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE790G01031
Shilpa Medicare Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SHILPAMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,311 | 3,093 | 2,904 | 2,876 | 2,632 | 1,989 | 1,610 | 1,499 | 1,472 | 931 |
| Current Assets | 986 | 877 | 770 | 887 | 903 | 624 | 545 | 672 | 730 | 354 |
| Fixed Assets | 1,418 | 1,385 | 1,368 | 1,342 | 1,111 | 650 | 558 | 534 | 492 | 393 |
| Liabilities | ||||||||||
| Total Liabilities | 3,311 | 3,093 | 2,904 | 2,876 | 2,632 | 1,989 | 1,610 | 1,499 | 1,472 | 931 |
| Current Liabilities | 273 | 600 | 345 | 453 | 561 | 257 | 167 | 154 | 251 | 67 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,364 | 1,800 | 1,774 | 1,811 | 1,468 | 1,322 | 1,190 | 1,080 | 984 | 642 |
| Share Capital | 10 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves & Surplus | 2,363 | 1,800 | 1,775 | 1,814 | 1,471 | 1,321 | 1,189 | 1,077 | 979 | 632 |
Screen SHILPAMED income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 372 | 328 | 341 | 321 | 349 | 302 | 300 | 289 | 315 | 262 | 266 | 266 | 267 | 269 | 346 |
| Expenses | 262 | 231 | 282 | 239 | 258 | 223 | 222 | 222 | 255 | 214 | 227 | 231 | 253 | 241 | 268 |
| EBITDA | 110 | 97 | 59 | 82 | 91 | 80 | 79 | 67 | 60 | 48 | 39 | 34 | 14 | 28 | 78 |
| Operating Profit % | 29.00% | 28.00% | 15.00% | 25.00% | 25.00% | 24.00% | 24.00% | 23.00% | 19.00% | 18.00% | 14.00% | 12.00% | 4.00% | 8.00% | 21.00% |
| Depreciation | 30 | 29 | 29 | 29 | 28 | 27 | 27 | 27 | 28 | 27 | 26 | 24 | 23 | 22 | 22 |
| Interest | 16 | 19 | 15 | 12 | 26 | 24 | 24 | 26 | 23 | 18 | 18 | 18 | 14 | 10 | 9 |
| Profit Before Tax | 64 | 50 | 15 | 42 | 37 | 29 | 28 | 14 | 9 | 3 | -4 | -8 | -22 | -4 | 46 |
| Tax | 20 | 3 | 1 | 10 | 19 | 15 | 3 | 10 | 8 | 2 | 4 | -1 | -4 | -6 | 17 |
| Net Profit | 44 | 47 | 15 | 32 | 18 | 14 | 25 | 5 | 2 | 1 | -8 | -7 | -19 | 2 | 30 |
| EPS | 5.50 | 4.79 | 1.48 | 3.25 | 1.83 | 1.46 | 2.82 | 0.53 | 0.19 | 0.14 | -0.93 | -0.76 | -2.15 | 0.10 | 3.40 |
Shilpa Medicare Cash Flow Screener - Liquidity Fundamentals
Screen SHILPAMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 132 | 137 | 180 | 105 | 47 | 124 | 147 | 45 | 38 | 129 |
| Investing Activities | -198 | -171 | -232 | -286 | -404 | -290 | -196 | -10 | -257 | -106 |
| Financing Activities | 63 | 47 | 46 | 83 | 436 | 176 | 10 | -61 | 313 | -20 |
| Net Cash Flow | -3 | 13 | -7 | -98 | 79 | 10 | -40 | -26 | 93 | 3 |
Screen SHILPAMED shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Apr | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.23% | 44.23% | 44.23% | 50.01% | 44.39% | 44.39% | 44.33% | 44.23% |
| FII Holding | 10.97% | 11.20% | 10.92% | 0.00% | 0.00% | 9.08% | 9.58% | 9.90% |
| DII Holding | 7.55% | 7.46% | 7.67% | 1.59% | 6.13% | 7.61% | 8.18% | 8.27% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 24.43% | 23.21% | 23.34% | 27.64% | 24.54% | 24.69% | 23.94% | 24.40% |
| Other Holding | 12.83% | 13.90% | 13.84% | 20.75% | 24.94% | 14.23% | 13.96% | 13.21% |
| Shareholder Count | 50,108 | 48,636 | 52,065 | 44,793 | 44,809 | 41,072 | 42,784 | 49,034 |
Shilpa Medicare Dividend Screener - Share Yield Analysis
Screen SHILPAMED dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.00 | 0.31% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.10 | 0.96% |
| 2021-March | ₹1.10 | 0.55% |
| 2020-March | ₹1.10 | 0.66% |
| 2019-March | ₹1.00 | 0.82% |
| 2018-March | ₹0.70 | 0.41% |
| 2017-March | ₹0.60 | 0.26% |
| 2016-March | ₹0.60 | 0.19% |
Shilpa Medicare Index Membership - Market Screener Classification
Screen SHILPAMED by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Shilpa Medicare Market Events Screener - Corporate Actions
Screen SHILPAMED market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.00 /share | 5.73% | ||
| Dividend | ₹ 1.10 /share | -10.81% | ||
| Annual General Meeting | NA | 26.59% | ||
| Dividend | ₹ 1.10 /share | 7.43% | ||
| Annual General Meeting | NA | -53.04% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 11.79% |
| 2025-10-03 | 2025-10-03 | Bonus | 1:1 | -5.18% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 2.33% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 10.39% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | 5.08% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 3.95% |
Shilpa Medicare Competitors Screener - Peer Comparison
Screen SHILPAMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Shilpa Medicare Company Announcements - News Screener
Screen SHILPAMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Ex-Parte Ad-Interim Injunction Order Regarding Pharmaceutical Drug Product Containing Ruxolitinib And/Or Ruxolitinib Salts API | View |
| 2026-01-03 | Closure of Trading Window | View |
| 2025-12-12 | Intimation Under Of Regulation 30 Of The SEBI(LODR) Regulations | View |
| 2025-11-22 | USFDA Inspection Of Shilpa Medicare Ltd. Unit IV Jadcherla Telangana | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-17 | Announcement Under Regulation 30 Of The SEBI(LODR) Regulations. | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Meeting Updates | View |
| 2025-11-13 | Outcome Of The Board Meeting Of The Company Held On 13 November 2025 | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 13 November 2025 | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-10 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-11-10 | Announcement Under Regulation 30 Of The SEBI(LODR) Regulations 2015 | View |
| 2025-11-10 | Announcement Under Regulation 30 Of The SEBI(LODR) Regulations 2015 | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-05 | Board Meeting Intimation for Consider And Approve Un-Audited Financial Results Of The Company For The Second Quarter And Half Year Ended 30 September 2025 | View |
| 2025-10-27 | Announcement Under Regulation 30 & 30(A) Of The SEBI (LODR) Regulations 2015 | View |
| 2025-10-16 | Intimation Under Regulation 30 Read With Regulation 30A And Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |